Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margret Schottelius

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|December 20, 2024
Identifying and navigating bottlenecks in the translation of novel radiopharmaceuticals: a perspectiveMargret Schottelius
European Journal of Nuclear Medicine and Molecular Imaging|February 11, 2020
"Luke! Luke! Don't! It's a trap!"-spotlight on bias in animal experiments in nuclear oncologyJulie Nonnekens, Margret Schottelius
Seminars in Nuclear Medicine|June 23, 2019
PSMA-Targeted Radiopharmaceuticals for Imaging and TherapyHans-Jürgen Wester, Margret Schottelius
Methods (San Diego, Calif.)|March 28, 2009
Molecular imaging targeting peptide receptorsMargret Schottelius, Hans-Jürgen Wester
Cancers|December 10, 2021
In Vivo Targeting of CXCR4-New HorizonsMargret Schottelius, Ken Herrmann, Constantin Lapa
Nuclear Medicine and Molecular Imaging|May 8, 2020
From Theranostics to Immunotheranostics: the ConceptNiklaus Schaefer, John O Prior, Margret Schottelius
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 22, 2018
New Developments in Peptide Receptor Radionuclide TherapyGuillaume P Nicolas, Alfred Morgenstern, Margret Schottelius, et al.
EJNMMI Research|September 23, 2016
Preclinical evaluation of [(68)Ga]NOTA-pentixafor for PET imaging of CXCR4 expression in vivo - a comparison to [(68)Ga]pentixaforAndreas Poschenrieder, Margret Schottelius, Markus Schwaiger, et al.
Accounts of Chemical Research|June 4, 2009
Ligands for mapping alphavbeta3-integrin expression in vivoMargret Schottelius, Burkhardt Laufer, Horst Kessler, et al.
EJNMMI Radiopharmacy and Chemistry|March 21, 2024
Validation of a size exclusion method for concomitant purification and formulation of peptide radiopharmaceuticalsSebastian Martin, Lennard Wendlinger, Alexandra Litvinenko, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
European Journal of Nuclear Medicine and Molecular Imaging|December 20, 2024
Identifying and navigating bottlenecks in the translation of novel radiopharmaceuticals: a perspectiveMargret Schottelius
European Journal of Nuclear Medicine and Molecular Imaging|February 11, 2020
"Luke! Luke! Don't! It's a trap!"-spotlight on bias in animal experiments in nuclear oncologyJulie Nonnekens, Margret Schottelius
Seminars in Nuclear Medicine|June 23, 2019
PSMA-Targeted Radiopharmaceuticals for Imaging and TherapyHans-Jürgen Wester, Margret Schottelius
Methods (San Diego, Calif.)|March 28, 2009
Molecular imaging targeting peptide receptorsMargret Schottelius, Hans-Jürgen Wester
Cancers|December 10, 2021
In Vivo Targeting of CXCR4-New HorizonsMargret Schottelius, Ken Herrmann, Constantin Lapa
Nuclear Medicine and Molecular Imaging|May 8, 2020
From Theranostics to Immunotheranostics: the ConceptNiklaus Schaefer, John O Prior, Margret Schottelius
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 22, 2018
New Developments in Peptide Receptor Radionuclide TherapyGuillaume P Nicolas, Alfred Morgenstern, Margret Schottelius, et al.
EJNMMI Research|September 23, 2016
Preclinical evaluation of [(68)Ga]NOTA-pentixafor for PET imaging of CXCR4 expression in vivo - a comparison to [(68)Ga]pentixaforAndreas Poschenrieder, Margret Schottelius, Markus Schwaiger, et al.
Accounts of Chemical Research|June 4, 2009
Ligands for mapping alphavbeta3-integrin expression in vivoMargret Schottelius, Burkhardt Laufer, Horst Kessler, et al.
EJNMMI Radiopharmacy and Chemistry|March 21, 2024
Validation of a size exclusion method for concomitant purification and formulation of peptide radiopharmaceuticalsSebastian Martin, Lennard Wendlinger, Alexandra Litvinenko, et al.
Pageof 10